[Vaccine for the prevention of Alzheimer's disease]
Ruiz Aragon J, Villegas Portero R
Record ID 32010001469
Spanish
Authors' recommendations:
Alzheimer’s disease is caused by the accumulation in certain areas of the brain of insoluble amyloid protein plaques, causing dementia, followed by steady mental deterioration.To prevent or delay the onset of the disease are investigated vaccines that mimic the amyloid peptide production, by stimulating the immune system making antibodies, which are safe, minimizing the possible adverse effects.No clinical trials or economic evaluation studies have been located that reveal results of safety, efficacy and cost of this new technology.There are numerous studies in experimental stage, investigating molecules for the creation of possible prophylactic measures for this type of dementia.
Details
Project Status:
Completed
URL for project:
https://www.aetsa.org/publicacion/vacuna-para-la-prevencion-de-la-enfermedad-de-alzheimer-informe-de-sintesis-de-tecnologia-emergente/
Year Published:
2010
URL for published report:
https://www.aetsa.org/download/publicaciones/antiguas/AETSA_2007-02-3_Vacuna_Alzheimer.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Spain
MeSH Terms
- Alzheimer Disease
Contact
Organisation Name:
Andalusian Health Technology Assessment Area
Contact Address:
Area de Evaluacion de Tecnologias Sanitarias Sanitarias de Andalucia (AETSA) Avda. Innovación, s/n Edificio Arena 1. Sevilla (Spain) Tel. +34 955 006 309
Contact Name:
aetsa.csalud@juntadeandalucia.es
Contact Email:
aetsa.csalud@juntadeandalucia.es
Copyright:
Andalusian Agency for Health Technology Assessment (AETSA)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.